Breast cancers found by screening: Earlier detection, lower malignant potential or both?

Breast Cancer Research and Treatment

Volumn 76, Issue 1, 2002, Pages 19-25

  Ernst, Miranda F ^a,g   Roukema, Jan A ^a,g   Coebergh, Jan Willem W ^b,c,g   Repelaer Van Driel, Ocker J ^d,g   Van Beek, Mike W P M ^e,g   Van Der Sangen, Maurice J C ^f,g   Voogd, Adri C ^b,g  

^a CPRLab   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Diaconessenhuis ^*  (Netherlands)

^e Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^f CATHARINA HOSPITAL   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast carcinoma; Mammography; Mass screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; ELECTRIC POTENTIAL; HUMAN; MITOSIS RATE; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MITOTIC INDEX; NETHERLANDS; POPULATION SURVEILLANCE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0036838069     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020213817562     Document Type: Article

References (21)

1. Cowan WK, Angus B, Henry J, Corbett IP, Reid WA, Horne CHW: Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening. Br J Cancer 64: 780-784, 1991
2. Cowan WK, Kelly P, Sawan A, Cunliffe WJ, Henry L, Higgs MJ, Lunt LG, Young JR, Horne CH, Angus B: The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol 182: 29-35, 1997
3. Klemi PJ, Joensuu H, Toikkanen S, Tuominen J, Rasanen O, Tyrkko J, Parvinen I: Aggressiveness of breast cancers found with and without screening. Br Med J 304: 467-469, 1992
4. Klemi PJ, Toikkanen S, Rasanen O, Parvinen I, Joensuu H: Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer 75: 762-766, 1997
5. Anderson TJ, Lamb J, Donnan P, Alexander FE, Huggins A, Muir BB, Kirkpatrick AE, Chetty U, Hepburn W, Smith A, Prescott RJ, Forrest P: Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer 64: 108-113, 1991
6. Crisp WJ, Higgs MJ, Cowan WK, Cunliffe WJ, Liston J, Lunt LG, Peakman DJ, Young JR: Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg 80: 863-865, 1993
7. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK: Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer 81: 877-880, 1999
8. Hakama M, Holli K, Isola J, Kallioniemi OP, Karkkainen A, Visakorpi T, Pukkala E, Saarenmaa I, Geiger U, Ikkala J, Nieminen T, Godenhjelm K, Koivula T: Aggressiveness of screen-detected breast cancers. Lancet 345: 221-224, 1995
9. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC: The natural history of breast carcinoma: what have we learned from screening? Cancer 86: 449-462, 1999
10. Norden T, Thurfjell E, Hasselgren M, Lindgren A, Norgren A, Bergstrom R, Holmberg L: Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer 33: 624-628, 1997
11. Holland PA, Walls J, Boggis CRM, Knox F, Baildam AD, Bundred NJ: A comparison of axillary node status between cancers detected at the prevalence and first incidence screening rounds. Br J Cancer 74: 1643-1646, 1996
12. Rajakariar R, Walker R: Pathological and biological features of mammographically detected invasive breast carcinomas. Br J Cancer 71: 150-154, 1995
13. Groenendijk RPR, Bult P, Tewarie L, Peer PGM, van der Sluis RF, Ruers TJM, Wobbes T: Screen-detected breast cancers have a lower mitotic activity index. Br J Cancer 82: 381-384, 2000
14. van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, Bellot SM, Fijnheer J, van Gorp LH, Kwee WS: Reproducibility of mitosis counting in 2469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23: 603-607, 1992
15. Hermanek P, Sobin LH (eds): UICC TNM Classification of Malignant Tumours. Springer-Verlag, Berlin, 198, pp 94-99
16. Tabar L, Fagerberg G, Day NE, Duffy SW, Kitchin RM: Breast cancer treatment and natural history: new insights from results of screening. Lancet 339: 412-414, 1992
17. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30: 187-210, 1992
18. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL, van Ineveld BM, de Bruyn AE, van der Maas PJ: Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 75: 694-698, 1998
19. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ: Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81: 912-917, 1999
20. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR: Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92: 743-749, 2000
21. Porter PL, El-Bastwissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E: Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91: 2020-2028, 1999